# Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

> **NCT00003434** · PHASE1 · TERMINATED · sponsor: **Duke University** · enrollment: 8 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** carcinoembryonic antigen peptide 1
- **BIOLOGICAL:** hepatitis B antigen peptide

## Key facts

- **NCT ID:** NCT00003434
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-06
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2014-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003434, "Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*